證監會恢復審查潤達醫療(603108.SH)可轉債發行申請
格隆匯12月3日丨潤達醫療(603108.SH)公佈,2019年8月12日,公司召開第三屆董事會第三十一次會議,由於公司控股股東、實際控制人擬發生變更,可能會導致公司本次公開發行A股可轉換公司債券發行條件發生變化,故此,向中國證監會申請中止審查本次公開發行A股可轉換公司債券申請文件。
2019年11月15日,公司召開了三屆董事會第三十六次會議(緊急),審議通過了《關於向中國證監會申請恢復審查公開發行A股可轉換公司債券申請文件的議案》。因下城國投與朱文怡等7名股東於2019年8月31日簽署了正式的《股份轉讓協議》及相關的《表決權委託協議》等協議,並已獲得各方所需的各類審批同意,於2019年10月30日完成股份交割,此次股份轉讓完成後,下城國投直接持有20.02%的公司股份、持有27.00%的公司股東大會表決權,成為公司控股股東,公司實際控制人由劉輝和朱文怡變更為杭州市下城區人民政府,故此,向中國證監會申請恢復審查本次公開發行A股可轉換公司債券申請文件。
2019年12月3日,公司收到中國證監會於2019年12月2日出具的第191461號《中國證監會行政許可恢復審查通知書》,根據《中國證券監督管理委員會行政許可實施程序規定》第二十三條的有關規定,決定恢復對該行政許可申請的審查。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.